Pharmaceutical Decisions, New Developments and Proposed Regulations Decisions and Regulations 09 October 2012 Pages: 283 - 286
Intellectual Property Right Protection for Pharmaceuticals in Developing Countries Y. Richard WangLei JiY. Aileen Lin Original Research Article 09 October 2012 Pages: 277 - 282
Recruitment and Retention Strategies for Clinical Trials in Alzheimer’s Disease Marwan N. SabbaghNancy ThompsonDonald J. Connor Practical Application 09 October 2012 Pages: 269 - 276
Practical Tools and Techniques for Project Planning and Control in Clinical Research Denise R. Wills Practical Application 09 October 2012 Pages: 261 - 268
Regulation of Herbal and Homeopathic Medicines Colin J. BriggsOlga Norrie Review Article 09 October 2012 Pages: 245 - 259
Postmarketing Drug Safety Surveillance Jasmanda H. WuMan C. FungEdmundo Muniz Review Article 09 October 2012 Pages: 231 - 244
The New US Federal Privacy Rules and Impact on Research Paul W. Radensky Current Opinion 09 October 2012 Pages: 225 - 230
Pharmaceutical Decisions, New Developments and Proposed Regulations Decisions and Regulations 09 October 2012 Pages: 215 - 221
Determining Consumer Willingness to Pay, Risk Behavior and Preferences Ola NorrieColleen J. Metge Original Research Article 09 October 2012 Pages: 205 - 213
Monitoring of Biomedical License Agreements George H. KellerSteven M. FergusonPercy Pan Practical Application 09 October 2012 Pages: 191 - 203
Bioequivalence Behind the Scenes Antonio Marzo Practical Application 09 October 2012 Pages: 179 - 189
Potential Expanded Use of Pharmacoeconomics and Outcomes Research in China Gordon G. LiuChunhui Liu Review Article 09 October 2012 Pages: 169 - 177
Predictive Software for Drug Design and Development Robert C. Jackson Leading Article 09 October 2012 Pages: 159 - 168
Equity, Access and Economic Evaluation in Rare Diseases Nick BosanquetGianfranco DomenighettiPaul Howard Current Opinion 09 October 2012 Pages: 151 - 157
Pharmaceutical Decisions, New Developments and Proposed Regulations Decisions and Regulations 09 October 2012 Pages: 145 - 149
Off-Label Drug Use in Children in Europe Chiara PandolfiniMaurizio Bonati Review Article 09 October 2012 Pages: 133 - 143
Applied Pharmacokinetics in Drug Development Gary W. CaldwellZhengyin YanDavid M. Ritchie Review Article 09 October 2012 Pages: 117 - 132
Facilitating Access to Vaccines Julie B. MilstienRoy Widdus Current Opinion 09 October 2012 Pages: 101 - 116
Clinical Trials in Japan After Implementation of the International Conference on Harmonization — Good Clinical Practice (ICH-GCP) Guidelines Shunsuke OnoKiichiro TsutaniKazuko Kimura Current Opinion 09 October 2012 Pages: 81 - 89
Pharmaceutical Decisions, New Developments and Proposed Regulations Decisions and Regulations 09 October 2012 Pages: 75 - 80
Parallel Importation of Pharmaceuticals in Finland Ismo LinnosmaaTaru KarhunenIlkka Vohlonen Original Research Article 09 October 2012 Pages: 67 - 74
Simulating the Impact of Price Regulation on Pharmaceutical Innovation John A. Vernon Original Research Article 09 October 2012 Pages: 55 - 65
Operational Protocol Models in the Drug Development Process Michael G. Kahn Practical Application 09 October 2012 Pages: 41 - 53
Internet-Based Clinical Trials Jules T. MitchelJoon YouPatrick O’Connor Practical Application 09 October 2012 Pages: 29 - 39
Generic Drug Regulation in the US Under the Hatch-Waxman Act Christopher-Paul MilneCatherine Cairns Leading Article 09 October 2012 Pages: 11 - 27